ReviewVaccines2022

Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.

Amina I Makandar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.